Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bruce David Walker, M.D.

Co-Author

This page shows the publications co-authored by Bruce Walker and Galit Alter.
Connection Strength

3.252
  1. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Netw Open. 2020 12 01; 3(12):e2030455.
    View in: PubMed
    Score: 0.237
  2. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Sci Immunol. 2018 08 17; 3(26).
    View in: PubMed
    Score: 0.202
  3. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity. AIDS. 2018 06 19; 32(10):1207-1217.
    View in: PubMed
    Score: 0.200
  4. High-resolution definition of humoral immune response correlates of effective immunity against HIV. Mol Syst Biol. 2018 03 26; 14(3):e7881.
    View in: PubMed
    Score: 0.197
  5. Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV. Clin Infect Dis. 2017 04 15; 64(8):1098-1104.
    View in: PubMed
    Score: 0.184
  6. HLA-C levels impact natural killer cell subset distribution and function. Hum Immunol. 2016 Dec; 77(12):1147-1153.
    View in: PubMed
    Score: 0.176
  7. Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016 Jun; 12(6):e1005694.
    View in: PubMed
    Score: 0.173
  8. Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016 Mar; 12(3):e1005456.
    View in: PubMed
    Score: 0.171
  9. Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunol. 2016 11; 9(6):1549-1558.
    View in: PubMed
    Score: 0.171
  10. Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control. PLoS Pathog. 2016 Jan; 12(1):e1005315.
    View in: PubMed
    Score: 0.169
  11. Acute HIV-1 Subtype C Infection Is Associated with Rapid Increase of Tissue-like Memory and Decrease in Resting Memory B-cells. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A211.
    View in: PubMed
    Score: 0.154
  12. An Inflammatory Profile that Predicts the Development of Neutralizing Antibody Breadth. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A35-6.
    View in: PubMed
    Score: 0.154
  13. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J Virol. 2009 Sep; 83(17):8705-12.
    View in: PubMed
    Score: 0.107
  14. Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection. J Virol. 2008 Oct; 82(19):9668-77.
    View in: PubMed
    Score: 0.100
  15. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med. 2006 Oct; 3(10):e403.
    View in: PubMed
    Score: 0.089
  16. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design. J Virol. 2005 Apr; 79(8):5000-5.
    View in: PubMed
    Score: 0.080
  17. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020 12 03; 383(23):2291-2293.
    View in: PubMed
    Score: 0.059
  18. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 10 30; 11(1):5493.
    View in: PubMed
    Score: 0.059
  19. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19. Cell. 2020 10 01; 183(1):143-157.e13.
    View in: PubMed
    Score: 0.058
  20. Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site. JCI Insight. 2018 03 08; 3(5).
    View in: PubMed
    Score: 0.049
  21. Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies. Front Immunol. 2017; 8:1104.
    View in: PubMed
    Score: 0.047
  22. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa. PLoS Med. 2015 Nov; 12(11):e1001900; discussion e1001900.
    View in: PubMed
    Score: 0.042
  23. Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma. PLoS One. 2015; 10(3):e0120434.
    View in: PubMed
    Score: 0.040
  24. Gp41 and p24 IgG Binding Antibody Titers Are Associated with HIV-1 Viral Control during Early HIV-1 Subtype C Infection. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A248.
    View in: PubMed
    Score: 0.039
  25. Association of HLA-DRB1-restricted CD4? T cell responses with HIV immune control. Nat Med. 2013 Jul; 19(7):930-3.
    View in: PubMed
    Score: 0.035
  26. Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection. J Virol. 2012 Jun; 86(12):6986-93.
    View in: PubMed
    Score: 0.033
  27. Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res Hum Retroviruses. 2010 Apr; 26(4):459-69.
    View in: PubMed
    Score: 0.028
  28. Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol. 2009 Feb; 83(4):1845-55.
    View in: PubMed
    Score: 0.026
  29. Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. Cancer Res. 2008 Nov 15; 68(22):9441-50.
    View in: PubMed
    Score: 0.026
  30. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008 May 06; 5(5):e100.
    View in: PubMed
    Score: 0.025
  31. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol. 2007 Jul; 81(14):7725-31.
    View in: PubMed
    Score: 0.023
  32. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis. 2006 Sep 15; 194(6):734-9.
    View in: PubMed
    Score: 0.022
  33. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol. 2005 Oct; 79(20):12952-60.
    View in: PubMed
    Score: 0.021
  34. High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level. AIDS. 2005 Sep 23; 19(14):1449-56.
    View in: PubMed
    Score: 0.021
  35. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med. 2004 Sep 20; 200(6):701-12.
    View in: PubMed
    Score: 0.019
  36. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood. 2004 Jul 15; 104(2):487-94.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.